HKBU receives HK$5 million donation from Consun Pharmaceutical Group Limited to establish a Chinese medicine research centre for renal diseases

5 February 2015


The University received a donation of HK$5 million from Consun Pharmaceutical Group Limited (Consun Group) for the establishment of a research centre under the School of Chinese Medicine (SCM). The aim of the new centre is to drive forward the School's research project and develop Chinese medicine for the prevention and treatment of renal diseases. In recognition of the generous support from the Consun Group, the University has named a laboratory in the Jockey Club School of Chinese Medicine Building the "Consun Chinese Medicines Research Centre for Renal Diseases". 

An agreement signing and cheque presentation ceremony was held by the University today (5 February). Officiating at the ceremony were Mr An Yubao, Chairman and Executive Director, Consun Pharmaceutical Group Limited, and Professor Albert Chan, President and Vice-Chancellor. Accompanying guests included Professor Zhu Quan, Executive Director and Chief Scientist, Consun Pharmaceutical Group Limited; Mr Gao Haien, Board Secretary and Joint Company Secretary, Consun Pharmaceutical Group Limited; Mr Cheng Yan-kee, Chairman of the Council and the Court, HKBU; Professor Rick Wong, Vice-President (Research and Development); and Professor Lu Aiping, Dean of SCM. At the ceremony, Mr An Yubao presented the HK$5 million cheque to Mr Cheng Yan-kee and Professor Albert Chan who received the donation on behalf of the University.

In his speech, Professor Albert Chan said the Consun Group shares the same vision and objective with SCM in the discovery of Chinese medicine treatments so as to benefit patients suffering from different kinds of illnesses. He believed that cooperation between business enterprises and tertiary institutions and research units is indeed a great combination that generates a win-win outcome. Professor Chan expressed his gratitude to the Consun Group for their confidence in SCM and hoped that the new research centre for renal diseases, set up with the support of the Consun Group, could continue its endeavours in new drug discovery in the future to help more renal disease patients through the concerted efforts of SCM's research team and related parties.

With the aim of fostering drug discovery for renal diseases to enhance public health, the donation of the Consun Group will support the research centre's project on research and development of Chinese medicine in related areas, which includes the setting up of a research team and construction of in vivo models.


Mr Cheng Yan-kee (centre) and Professor Albert Chan (sixth from right) receive the HK$5 million donation from Mr An Yubao (fifth from left) on behalf of HKBU


(From left) Professor Lu Aiping, Professor Zhu Quan, Mr Cheng Yan-kee, and Mr An Yubao visit the newly established "Consun Chinese Medicines Research Centre for Renal Diseases" after the ceremony